Investors tracking the artificial-intelligence (AI) buildout in semiconductors often compare equipment and packaging suppliers side by side. AEHR, Aehr Test Systems, develops wafer-level and package-level burn-in and test systems used to improve chip reliability. AMKR, Amkor Technology, is one of the world's largest outsourced semiconductor assembly and test (OSAT) providers, handling advanced packaging for computing, automotive, and communications chips. Although both companies are exposed to the same AI infrastructure theme, they occupy different points in the supply chain and carry very different risk and valuation profiles. This comparison is most relevant to growth-oriented traders assessing momentum and catalysts against stability-oriented investors weighing profitability and balance-sheet quality. When evaluating names in this space, I sometimes run a quick screen with Tickeron’s AI Screener to put relative metrics in perspective.
AEHR sells semiconductor test and burn-in systems, including its FOX wafer-level and Sonoma package-level platforms, which are increasingly tied to AI processors and high-performance computing. Recent weeks brought a sharp swing in the stock's narrative. The company reported record quarterly revenue of roughly $33 million, up about 200% year over year and 75% sequentially, and swung from a net loss to a profit of about $7.2 million. Bookings reached approximately $46.7 million, and effective backlog climbed to around $109 million, supporting management's decision to raise its fiscal 2027 revenue outlook to $150 million.
That operational strength triggered a single-session gain of more than 25%, yet the stock had already pulled back sharply in the preceding months, reflecting profit-taking and a cooling of valuation multiples across semiconductor capital-equipment names. The shares remain highly volatile, with a 52-week trading range spanning from roughly $19 to more than $147. Despite a strong year-to-date advance, the elevated P/S ratio and a concentrated AI customer base are among the factors that continue to shape sentiment. I also checked this using Tickeron’s AI Trend Prediction Engine to gauge how the recent move aligns with broader sector patterns.
AMKR provides outsourced packaging and test services, including advanced packaging for AI and data-center processors, with a footprint spanning the United States, South Korea, and other regions. In its most recent quarter, revenue was roughly flat year over year at about $1.99 billion, while net income rose about 51% to approximately $190.6 million. Gross margin expanded to 18.3%, driven by strength in Computing and Automotive & Industrial segments, both of which reached record revenue levels.
That margin progress was partly offset by softness in the Communications segment, where smartphone demand and component shortages weighed on results, and management issued fourth-quarter guidance below market expectations. The shares rallied after the report on the margin story but remain below their 52-week highs. AMKR is executing a substantial capital-expenditure (capex) program, including an Arizona advanced-packaging campus expansion, which offers long-term AI leverage but also raises near-term utilization and return considerations.
The two companies differ most clearly in scale, business model, and valuation. AMKR is a far larger, profitable OSAT with diversified end markets and a modest dividend, giving it a more stable earnings base but slower top-line growth. AEHR is a smaller, earlier-stage equipment maker with concentrated AI-driven demand, delivering much faster revenue growth but at a premium multiple and with higher earnings volatility.
Growth drivers also diverge. AMKR benefits from the secular shift to advanced packaging and a geopolitically diversified manufacturing footprint, though near-term guidance is tempered by smartphone weakness and heavy capex. AEHR benefits directly from rising AI accelerator volumes and an expanding backlog, though its fortunes hinge on a narrower set of large customers and production ramps. In terms of momentum, AEHR has shown stronger year-to-date gains despite recent pullbacks, while AMKR offers more stable, if less explosive, relative performance.
On balance, Tickeron's AI would currently favor AEHR over AMKR, based on its stronger growth trajectory, record bookings and backlog, recent swing to profitability, and more direct exposure to AI semiconductor demand. These factors suggest more pronounced positive catalysts and trend momentum, even though the stock's elevated valuation and volatility introduce greater downside risk. AMKR presents a more stable and profitable profile, but its near-flat revenue growth and below-consensus guidance weigh on relative positioning. This assessment reflects observable momentum and catalyst factors and is expressed in probabilistic terms rather than as a definitive forecast.
In my own work comparing names like these, I find Tickeron’s AI Trading Bots helpful for understanding how different automated strategies are currently positioned. The platform’s library covers thousands of tickers across varied timeframes and risk parameters, and the curated Trending AI Robots section makes it easier to focus on approaches that match prevailing market conditions without forcing a single model on every situation.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Financial analyst and market blogger with expertise in equity research, fundamental analysis, and macroeconomic trends. I regularly publish coverage on individual stocks, ETFs, and sector developments — combining rigorous financial analysis with clear, engaging writing for a broad investment audience.
The 10-day moving average for AEHR crossed bearishly below the 50-day moving average on October 09, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 14 of 16 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 88%.
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 54 of 63 cases where AEHR's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 86%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where AEHR declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 84%.
The Aroon Indicator for AEHR entered a downward trend on November 13, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where AEHR's RSI Oscillator exited the oversold zone, 29 of 31 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 90%.
The Momentum Indicator moved above the 0 level on November 13, 2026. You may want to consider a long position or call options on AEHR as a result. In 71 of 85 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 84%.
The Moving Average Convergence Divergence (MACD) for AEHR just turned positive on November 03, 2026. Looking at past instances where AEHR's MACD turned positive, the stock continued to rise in 35 of 38 cases over the following month. The odds of a continued upward trend are 90%.
Following a +21.66% 3-day Advance, the price is estimated to grow further. Considering data from situations where AEHR advanced for three days, in 243 of 272 cases, the price rose further within the following month. The odds of a continued upward trend are 89%.
AEHR may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Tickeron Valuation Rating of 4 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (7.970) is normal, around the industry mean (5.670). AEHR has a moderately low P/E Ratio (-232.913) as compared to the industry average of (68.795). Projected Growth (PEG Ratio) (0.927) is also within normal values, averaging (0.801). Dividend Yield (0.000) settles around the average of (0.009) among similar stocks. P/S Ratio (51.813) is also within normal values, averaging (27.897).
The Tickeron PE Growth Rating for this company is 14 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 61 (best 1 - 100 worst), indicating steady price growth. AEHR’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 74 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. AEHR’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 77, placing this stock better than average.
The Tickeron SMR rating for this company is 92 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a manufacturer of burn-in and test equipment for semiconductor manufacturing
Industry ElectronicProductionEquipment